SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6upj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.80A 1c6yA-6upjA:
18.2		 1c6yA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.85A 1c6yA-6upjA:
18.2		 1c6yA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.47A 1c6yB-6upjA:
17.7		 1c6yB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
None
 0.67A 1c6yB-6upjA:
17.7		 1c6yB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  50
THR A  80
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
 0.65A 1c6yB-6upjA:
17.7		 1c6yB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.49A 1c6zA-6upjA:
17.9		 1c6zA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.52A 1c6zA-6upjA:
17.9		 1c6zA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.63A 1c6zA-6upjA:
17.9		 1c6zA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
GLY A  27
ASP A  30
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
 0.71A 1c6zA-6upjA:
17.9		 1c6zA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.62A 1c6zB-6upjA:
18.1		 1c6zB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.78A 1c6zB-6upjA:
18.1		 1c6zB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.44A 1c6zB-6upjA:
18.1		 1c6zB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4S_A_TPVA201_1
(PROTEIN (HIV-1
PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.76A 1d4sA-6upjA:
18.2		 1d4sA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.61A 1d4yA-6upjA:
18.2		 1d4yA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.73A 1d4yA-6upjA:
18.2		 1d4yA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.15A 1d4yA-6upjA:
18.2		 1d4yA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.62A 1fb7A-6upjA:
17.9		 1fb7A-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
None
 0.49A 1fb7A-6upjA:
17.9		 1fb7A-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.79A 1fb7A-6upjA:
17.9		 1fb7A-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 GLY A  27
ASP A  29
ASP A  30
ILE A  50
THR A  80
PRO A  81
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
None
 0.76A 1fb7A-6upjA:
17.9		 1fb7A-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.81A 1hpvA-6upjA:
18.2		 1hpvA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.64A 1hpvB-6upjA:
18.2		 1hpvB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.88A 1hpvB-6upjA:
18.2		 1hpvB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.86A 1hpvB-6upjA:
18.2		 1hpvB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.72A 1hsgA-6upjA:
17.9		 1hsgA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.71A 1hsgA-6upjA:
17.9		 1hsgA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
None
 0.53A 1hsgB-6upjA:
17.9		 1hsgB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
 0.53A 1hsgB-6upjA:
17.9		 1hsgB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.70A 1hsgB-6upjA:
17.9		 1hsgB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.40A 1hsgB-6upjA:
17.9		 1hsgB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_2
(HIV-II PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 ASP A  25
ALA A  28
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.68A 1hshB-6upjA:
18.8		 1hshB-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_2
(HIV-II PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 ASP A  25
ALA A  28
ILE A  32
VAL A  47
GLY A  49
PRO A  81
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
NIU  A 100 (-4.6A)
None
 0.69A 1hshB-6upjA:
18.8		 1hshB-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  30
ILE A  32
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.65A 1hshC-6upjA:
19.1		 1hshC-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-4.6A)
None
 0.66A 1hshC-6upjA:
19.1		 1hshC-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
GLY A  27
ASP A  29
ASP A  30
ILE A  50
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
 0.66A 1hshC-6upjA:
19.1		 1hshC-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
ALA A  28
ASP A  30
ILE A  32
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.63A 1hshC-6upjA:
19.1		 1hshC-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
PRO A  81
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
NIU  A 100 (-4.6A)
None
 0.57A 1hshC-6upjA:
19.1		 1hshC-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  27
ASP A  29
ASP A  30
ILE A  50
PRO A  81
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
 0.64A 1hshC-6upjA:
19.1		 1hshC-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
None
 0.61A 1hxbA-6upjA:
18.0		 1hxbA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 GLY A  27
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-4.5A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.82A 1hxbA-6upjA:
18.0		 1hxbA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.83A 1hxbB-6upjA:
18.0		 1hxbB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.58A 1hxbB-6upjA:
18.0		 1hxbB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.59A 1hxbB-6upjA:
18.0		 1hxbB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.83A 1hxbB-6upjA:
18.0		 1hxbB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
None
NIU  A 100 (-3.9A)
None
None
 0.68A 1hxbB-6upjA:
18.0		 1hxbB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_4
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 4 GLY A  27
ASP A  29
GLY A  48
THR A  80
 NIU  A 100 (-4.5A)
None
None
None
 0.62A 1hxbB-6upjA:
18.0		 1hxbB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
None
None
None
None
 1.10A 1hxwA-6upjA:
18.1		 1hxwA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.37A 1hxwA-6upjA:
18.1		 1hxwA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.90A 1hxwA-6upjA:
18.1		 1hxwA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.03A 1hxwB-6upjA:
17.5		 1hxwB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.89A 1hxwB-6upjA:
17.5		 1hxwB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  48
GLY A  49
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.68A 1k6cA-6upjA:
18.0		 1k6cA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  48
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.65A 1k6cA-6upjA:
18.0		 1k6cA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.89A 1k6cB-6upjA:
18.1		 1k6cB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.91A 1muiA-6upjA:
18.1		 1muiA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.62A 1muiA-6upjA:
18.1		 1muiA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.78A 1muiA-6upjA:
18.1		 1muiA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
GLY A  27
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.91A 1n49B-6upjA:
17.9		 1n49B-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.75A 1n49B-6upjA:
17.9		 1n49B-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
GLY A  27
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.87A 1n49C-6upjA:
17.9		 1n49C-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.62A 1n49C-6upjA:
17.9		 1n49C-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.63A 1n49C-6upjA:
17.9		 1n49C-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 6 ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.93A 1n49D-6upjA:
18.0		 1n49D-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
None
 0.75A 1ohrA-6upjA:
18.1		 1ohrA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ASP A  29
ASP A  30
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 1.04A 1ohrA-6upjA:
18.1		 1ohrA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.95A 1ohrA-6upjA:
18.1		 1ohrA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_2
(ASPARTYLPROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.93A 1ohrB-6upjA:
17.3		 1ohrB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.91A 1sdtA-6upjA:
18.0		 1sdtA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ARG A   8
LEU A  23
ASP A  25
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.9A)
None
 0.85A 1sdtA-6upjA:
18.0		 1sdtA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.71A 1sdtA-6upjA:
18.0		 1sdtA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.85A 1sdtB-6upjA:
17.7		 1sdtB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
None
 0.66A 1sdtB-6upjA:
17.7		 1sdtB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ARG A   8
LEU A  23
ASP A  25
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.9A)
None
 0.87A 1sduA-6upjA:
17.8		 1sduA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.72A 1sduA-6upjA:
17.8		 1sduA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.80A 1sduA-6upjA:
17.8		 1sduA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.46A 1sduB-6upjA:
18.0		 1sduB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
None
None
 0.65A 1sduB-6upjA:
18.0		 1sduB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.42A 1sduB-6upjA:
18.0		 1sduB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.83A 1sdvA-6upjA:
18.1		 1sdvA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.99A 1sdvA-6upjA:
18.1		 1sdvA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.46A 1sdvB-6upjA:
17.7		 1sdvB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.82A 1sdvB-6upjA:
17.7		 1sdvB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.82A 1sdvB-6upjA:
17.7		 1sdvB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.61A 1sguB-6upjA:
18.7		 1sguB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.61A 1sguB-6upjA:
18.7		 1sguB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SH9_B_RITB301_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 ASP A  25
GLY A  27
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.82A 1sh9B-6upjA:
18.7		 1sh9B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.46A 1t3rA-6upjA:
18.0		 1t3rA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.68A 1t3rA-6upjA:
18.0		 1t3rA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
 0.71A 1t3rB-6upjA:
17.6		 1t3rB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.84A 1t3rB-6upjA:
17.6		 1t3rB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.01A 1t3rB-6upjA:
17.6		 1t3rB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.92A 1t3rB-6upjA:
17.6		 1t3rB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.78A 1t3rB-6upjA:
17.6		 1t3rB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.81A 1t3rB-6upjA:
17.6		 1t3rB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.94A 1t3rB-6upjA:
17.6		 1t3rB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.47A 1t7iA-6upjA:
17.8		 1t7iA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.72A 1t7iA-6upjA:
17.8		 1t7iA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOF_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 5 ASP A  25
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.61A 2aofA-6upjA:
18.2		 2aofA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOF_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 5 LEU A  23
ASP A  25
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
 0.47A 2aofB-6upjA:
17.8		 2aofB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOH_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.58A 2aohA-6upjA:
18.2		 2aohA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOI_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 5 ASP A  25
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.60A 2aoiA-6upjA:
18.1		 2aoiA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOI_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 5 LEU A  23
ASP A  25
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
 0.50A 2aoiB-6upjA:
17.8		 2aoiB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOJ_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.59A 2aojA-6upjA:
18.1		 2aojA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.82A 2aquA-6upjA:
18.0		 2aquA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.78A 2aquB-6upjA:
17.9		 2aquB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.82A 2avoA-6upjA:
17.6		 2avoA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.85A 2avoA-6upjA:
17.6		 2avoA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
 0.69A 2avsA-6upjA:
17.9		 2avsA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.61A 2avsA-6upjA:
17.9		 2avsA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.46A 2avsB-6upjA:
17.8		 2avsB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
None
None
 0.63A 2avsB-6upjA:
17.8		 2avsB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.43A 2avsB-6upjA:
17.8		 2avsB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.75A 2avvA-6upjA:
17.9		 2avvA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  30
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
 0.64A 2avvA-6upjA:
17.9		 2avvA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  48
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.75A 2avvA-6upjA:
17.9		 2avvA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
None
 0.69A 2avvA-6upjA:
17.9		 2avvA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
None
 0.67A 2avvD-6upjA:
18.0		 2avvD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.64A 2avvD-6upjA:
18.0		 2avvD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.58A 2avvD-6upjA:
18.0		 2avvD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.62A 2avvE-6upjA:
17.9		 2avvE-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.65A 2avvE-6upjA:
17.9		 2avvE-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
GLY A  27
ASP A  29
ASP A  30
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
 0.85A 2avvE-6upjA:
17.9		 2avvE-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.86A 2avvE-6upjA:
17.9		 2avvE-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.62A 2b60A-6upjA:
18.6		 2b60A-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.61A 2b60B-6upjA:
18.6		 2b60B-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.50A 2b60B-6upjA:
18.6		 2b60B-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.73A 2b60B-6upjA:
18.6		 2b60B-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.73A 2b7zA-6upjA:
18.5		 2b7zA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.66A 2b7zA-6upjA:
18.5		 2b7zA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
ASP A  25
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.70A 2b7zB-6upjA:
18.5		 2b7zB-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.63A 2b7zB-6upjA:
18.5		 2b7zB-6upjA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BLA_A_CP6A302_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ILE A  36
ALA A  34
MET A  76
ILE A  89
ILE A  15
 None
 1.27A 2blaA-6upjA:
undetectable		 2blaA-6upjA:
20.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.74A 2f80A-6upjA:
18.0		 2f80A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.70A 2f80A-6upjA:
18.0		 2f80A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.97A 2f80A-6upjA:
18.0		 2f80A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.97A 2f80A-6upjA:
18.0		 2f80A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.63A 2f80B-6upjA:
17.7		 2f80B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.65A 2f80B-6upjA:
17.7		 2f80B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.80A 2f80B-6upjA:
17.7		 2f80B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.84A 2f80B-6upjA:
17.7		 2f80B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.76A 2f81A-6upjA:
17.9		 2f81A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.70A 2f81A-6upjA:
17.9		 2f81A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.99A 2f81A-6upjA:
17.9		 2f81A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
GLY A  27
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.92A 2f81A-6upjA:
17.9		 2f81A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.65A 2f81B-6upjA:
17.5		 2f81B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.70A 2f81B-6upjA:
17.5		 2f81B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.77A 2f81B-6upjA:
17.5		 2f81B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.83A 2f81B-6upjA:
17.5		 2f81B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.56A 2f81B-6upjA:
17.5		 2f81B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
 0.58A 2f81B-6upjA:
17.5		 2f81B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.98A 2f81B-6upjA:
17.5		 2f81B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.69A 2f8gA-6upjA:
18.1		 2f8gA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.67A 2f8gA-6upjA:
18.1		 2f8gA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_1
(POL PROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.87A 2fxdA-6upjA:
17.3		 2fxdA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 7 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.77A 2fxdB-6upjA:
17.8		 2fxdB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 7 ARG A   8
ASP A  25
ALA A  28
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.86A 2fxdB-6upjA:
17.8		 2fxdB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 7 ARG A   8
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.87A 2fxdB-6upjA:
17.8		 2fxdB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.85A 2fxeB-6upjA:
18.0		 2fxeB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.42A 2fxeB-6upjA:
18.0		 2fxeB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.00A 2fxeB-6upjA:
18.0		 2fxeB-6upjA:
49.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2H4J_A_NCAA1002_0
(NAD-DEPENDENT
DEACETYLASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 5 ALA A  34
ILE A  32
ASN A  83
ILE A  82
 None
None
None
NIU  A 100 (-4.6A)
 1.06A 2h4jA-6upjA:
undetectable		 2h4jA-6upjA:
21.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
 0.59A 2hs1A-6upjA:
16.7		 2hs1A-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.70A 2hs1A-6upjA:
16.7		 2hs1A-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.95A 2hs1B-6upjA:
17.7		 2hs1B-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ILE A  32
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.64A 2hs1B-6upjA:
17.7		 2hs1B-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.76A 2hs1B-6upjA:
17.7		 2hs1B-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.59A 2hs1B-6upjA:
17.7		 2hs1B-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.88A 2hs1B-6upjA:
17.7		 2hs1B-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.63A 2hs2A-6upjA:
16.9		 2hs2A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.66A 2hs2A-6upjA:
16.9		 2hs2A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.45A 2hs2A-6upjA:
16.9		 2hs2A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.79A 2hs2A-6upjA:
16.9		 2hs2A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.75A 2hs2A-6upjA:
16.9		 2hs2A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.72A 2hs2A-6upjA:
16.9		 2hs2A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.98A 2hs2A-6upjA:
16.9		 2hs2A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.94A 2hs2A-6upjA:
16.9		 2hs2A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
ILE A  84
 None
None
NIU  A 100 (-2.8A)
None
None
 0.68A 2hs2B-6upjA:
17.9		 2hs2B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.72A 2hs2B-6upjA:
17.9		 2hs2B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.92A 2hs2B-6upjA:
17.9		 2hs2B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.68A 2hs2B-6upjA:
17.9		 2hs2B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.80A 2hs2B-6upjA:
17.9		 2hs2B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.64A 2idwA-6upjA:
17.6		 2idwA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
None
None
 0.75A 2idwA-6upjA:
17.6		 2idwA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.44A 2idwB-6upjA:
18.2		 2idwB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.65A 2idwB-6upjA:
18.2		 2idwB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.64A 2ienB-6upjA:
17.6		 2ienB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.67A 2ienB-6upjA:
17.6		 2ienB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.73A 2ienB-6upjA:
17.6		 2ienB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.62A 2ieoB-6upjA:
17.7		 2ieoB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.82A 2ieoB-6upjA:
17.7		 2ieoB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.64A 2ieoB-6upjA:
17.7		 2ieoB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.76A 2ieoB-6upjA:
17.7		 2ieoB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
None
 0.79A 2nmyA-6upjA:
18.2		 2nmyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.38A 2nmyA-6upjA:
18.2		 2nmyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ARG A   8
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
None
 0.97A 2nmyA-6upjA:
18.2		 2nmyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
None
None
 1.11A 2nmyA-6upjA:
18.2		 2nmyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 1.38A 2nmyA-6upjA:
18.2		 2nmyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.68A 2nmyB-6upjA:
18.0		 2nmyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.83A 2nmyB-6upjA:
18.0		 2nmyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.57A 2nmyB-6upjA:
18.0		 2nmyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.73A 2nmyB-6upjA:
18.0		 2nmyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.60A 2nnkA-6upjA:
17.6		 2nnkA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.76A 2nnkA-6upjA:
17.6		 2nnkA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
ASP A  29
ASP A  30
ILE A  50
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
 0.80A 2nnkA-6upjA:
17.6		 2nnkA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.00A 2nnkA-6upjA:
17.6		 2nnkA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
None
 0.97A 2nnpA-6upjA:
17.5		 2nnpA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.85A 2nnpA-6upjA:
17.5		 2nnpA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.45A 2nnpA-6upjA:
17.5		 2nnpA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.03A 2nnpA-6upjA:
17.5		 2nnpA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.71A 2nnpB-6upjA:
18.0		 2nnpB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
ALA A  28
ASP A  29
GLY A  49
PRO A  81
 None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.98A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
ALA A  28
GLY A  49
PHE A  53
PRO A  81
 None
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.90A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.10A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.98A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
GLY A  49
ILE A  50
PHE A  53
PRO A  81
 None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.88A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
ALA A  28
GLY A  48
GLY A  49
PHE A  53
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
None
 0.67A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  48
GLY A  49
ILE A  50
PHE A  53
PRO A  81
 None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.52A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.71A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.65A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.95A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.12A 2o4kA-6upjA:
18.0		 2o4kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.62A 2o4lA-6upjA:
18.1		 2o4lA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.60A 2o4lA-6upjA:
18.1		 2o4lA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.52A 2o4lA-6upjA:
18.1		 2o4lA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.56A 2o4lA-6upjA:
18.1		 2o4lA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.89A 2o4pA-6upjA:
18.0		 2o4pA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.89A 2o4pA-6upjA:
18.0		 2o4pA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.49A 2o4pA-6upjA:
18.0		 2o4pA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.81A 2o4pB-6upjA:
17.6		 2o4pB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.70A 2o4sA-6upjA:
18.1		 2o4sA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.82A 2o4sA-6upjA:
18.1		 2o4sA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.80A 2o4sA-6upjA:
18.1		 2o4sA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.49A 2o4sA-6upjA:
18.1		 2o4sA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.62A 2o4sA-6upjA:
18.1		 2o4sA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.82A 2o4sA-6upjA:
18.1		 2o4sA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  27
ASP A  29
ASP A  30
ILE A  50
ILE A  84
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
 0.64A 2o4sA-6upjA:
18.1		 2o4sA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  27
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
None
 0.79A 2o4sA-6upjA:
18.1		 2o4sA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
 0.60A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  29
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
 0.75A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
 0.60A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.9A)
None
None
 0.81A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.68A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.52A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.84A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.50A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.54A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.76A 2o4sB-6upjA:
17.8		 2o4sB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.68A 2pymA-6upjA:
18.2		 2pymA-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.61A 2pymA-6upjA:
18.2		 2pymA-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
ASP A  29
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
 0.92A 2pymA-6upjA:
18.2		 2pymA-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
None
 0.74A 2pymB-6upjA:
18.1		 2pymB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
GLY A  27
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.88A 2pymB-6upjA:
18.1		 2pymB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.67A 2pymB-6upjA:
18.1		 2pymB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.64A 2pymB-6upjA:
18.1		 2pymB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.70A 2pynA-6upjA:
18.5		 2pynA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.80A 2pynA-6upjA:
18.5		 2pynA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.75A 2pynB-6upjA:
18.4		 2pynB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.68A 2pynB-6upjA:
18.4		 2pynB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.65A 2pynB-6upjA:
18.4		 2pynB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.72A 2pynB-6upjA:
18.4		 2pynB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.96A 2q5kA-6upjA:
17.8		 2q5kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.95A 2q5kA-6upjA:
17.8		 2q5kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 1.42A 2q5kA-6upjA:
17.8		 2q5kA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.80A 2q5kB-6upjA:
18.2		 2q5kB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 (-3.9A)
None
 0.90A 2q5kB-6upjA:
18.2		 2q5kB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.81A 2q5kB-6upjA:
18.2		 2q5kB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.77A 2q5kB-6upjA:
18.2		 2q5kB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
None
 0.69A 2q63B-6upjA:
18.1		 2q63B-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
GLY A  27
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.80A 2q63B-6upjA:
18.1		 2q63B-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.74A 2q63B-6upjA:
18.1		 2q63B-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.90A 2q63B-6upjA:
18.1		 2q63B-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.69A 2q64A-6upjA:
18.1		 2q64A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.74A 2q64A-6upjA:
18.1		 2q64A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_4
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.51A 2q64B-6upjA:
18.0		 2q64B-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.75A 2qakB-6upjA:
18.1		 2qakB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.66A 2qakB-6upjA:
18.1		 2qakB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.59A 2qhcA-6upjA:
17.8		 2qhcA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.76A 2qhcA-6upjA:
17.8		 2qhcA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.38A 2qhcA-6upjA:
17.8		 2qhcA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.61A 2qhcA-6upjA:
17.8		 2qhcA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.80A 2qhcA-6upjA:
17.8		 2qhcA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.67A 2qhcB-6upjA:
17.9		 2qhcB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.65A 2qhcB-6upjA:
17.9		 2qhcB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.71A 2r5pA-6upjA:
18.3		 2r5pA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ASP A  30
GLY A  48
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.64A 2r5pA-6upjA:
18.3		 2r5pA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.71A 2r5pC-6upjA:
18.3		 2r5pC-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ASP A  30
GLY A  48
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.65A 2r5pC-6upjA:
18.3		 2r5pC-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.80A 2r5qA-6upjA:
18.1		 2r5qA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.72A 2r5qA-6upjA:
18.1		 2r5qA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.81A 2r5qB-6upjA:
17.9		 2r5qB-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.80A 2r5qC-6upjA:
18.1		 2r5qC-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.72A 2r5qC-6upjA:
18.1		 2r5qC-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.81A 2r5qD-6upjA:
17.9		 2r5qD-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
None
 0.61A 2rkfA-6upjA:
18.2		 2rkfA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.66A 2rkfA-6upjA:
18.2		 2rkfA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
ALA A  28
ASP A  30
ILE A  32
VAL A  47
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
None
 0.55A 2rkgB-6upjA:
18.2		 2rkgB-6upjA:
49.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
None
 0.60A 2rkgB-6upjA:
18.2		 2rkgB-6upjA:
49.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
ASP A  30
ILE A  32
VAL A  47
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
None
NIU  A 100 ( 3.8A)
None
None
 0.60A 2rkgB-6upjA:
18.2		 2rkgB-6upjA:
49.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  32
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
NIU  A 100 ( 3.8A)
None
None
 0.63A 2rkgB-6upjA:
18.2		 2rkgB-6upjA:
49.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.82A 2rkgB-6upjA:
18.2		 2rkgB-6upjA:
49.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
VAL A  47
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.76A 2rkgB-6upjA:
18.2		 2rkgB-6upjA:
49.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
None
 0.63A 2z54A-6upjA:
17.9		 2z54A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.73A 2z54A-6upjA:
17.9		 2z54A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.61A 2z54A-6upjA:
17.9		 2z54A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.76A 2z54A-6upjA:
17.9		 2z54A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.85A 3cywA-6upjA:
17.9		 3cywA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.70A 3cywA-6upjA:
17.9		 3cywA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.66A 3cywA-6upjA:
17.9		 3cywA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
None
None
 0.88A 3cywA-6upjA:
17.9		 3cywA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
None
None
 0.76A 3cywA-6upjA:
17.9		 3cywA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
 0.71A 3cywA-6upjA:
17.9		 3cywA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.85A 3cywB-6upjA:
18.0		 3cywB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.63A 3cywB-6upjA:
18.0		 3cywB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.77A 3cywB-6upjA:
18.0		 3cywB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.78A 3cyxA-6upjA:
18.0		 3cyxA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.66A 3cyxA-6upjA:
18.0		 3cyxA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.72A 3cyxB-6upjA:
17.9		 3cyxB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.51A 3cyxB-6upjA:
17.9		 3cyxB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.69A 3d1xB-6upjA:
17.8		 3d1xB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
GLY A  27
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.85A 3d1xB-6upjA:
17.8		 3d1xB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.73A 3d1xB-6upjA:
17.8		 3d1xB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.87A 3d1xB-6upjA:
17.8		 3d1xB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ARG A   8
ASP A  25
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.84A 3d1yB-6upjA:
17.8		 3d1yB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.89A 3d1yB-6upjA:
17.8		 3d1yB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
ASP A  25
ALA A  28
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.65A 3d1zA-6upjA:
17.7		 3d1zA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.52A 3d1zA-6upjA:
17.7		 3d1zA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.66A 3d1zA-6upjA:
17.7		 3d1zA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.78A 3d1zB-6upjA:
17.7		 3d1zB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.78A 3d1zB-6upjA:
17.7		 3d1zB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.68A 3d1zB-6upjA:
17.7		 3d1zB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.08A 3d1zB-6upjA:
17.7		 3d1zB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
None
 0.71A 3d20A-6upjA:
18.0		 3d20A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.69A 3d20A-6upjA:
18.0		 3d20A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.92A 3d20A-6upjA:
18.0		 3d20A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.61A 3d20B-6upjA:
17.6		 3d20B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.70A 3d20B-6upjA:
17.6		 3d20B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.88A 3d20B-6upjA:
17.6		 3d20B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  32
PRO A  81
ILE A  82
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-4.6A)
None
 0.66A 3ebzA-6upjA:
18.9		 3ebzA-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.79A 3ebzA-6upjA:
18.9		 3ebzA-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.91A 3ebzA-6upjA:
18.9		 3ebzA-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
None
NIU  A 100 (-3.9A)
None
NIU  A 100 (-4.6A)
None
 0.86A 3ebzA-6upjA:
18.9		 3ebzA-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  82
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-4.6A)
 0.69A 3ebzB-6upjA:
19.0		 3ebzB-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.70A 3ebzB-6upjA:
19.0		 3ebzB-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
VAL A  47
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.66A 3ebzB-6upjA:
19.0		 3ebzB-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  82
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
NIU  A 100 (-4.6A)
 0.80A 3ebzB-6upjA:
19.0		 3ebzB-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ILE A  32
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.81A 3ebzB-6upjA:
19.0		 3ebzB-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ILE A  32
VAL A  47
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.77A 3ebzB-6upjA:
19.0		 3ebzB-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.83A 3ekpB-6upjA:
17.9		 3ekpB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.81A 3ekpC-6upjA:
18.0		 3ekpC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
None
 1.04A 3ekqA-6upjA:
17.8		 3ekqA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 1.39A 3ekqA-6upjA:
17.8		 3ekqA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.47A 3ekqA-6upjA:
17.8		 3ekqA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.78A 3ekqA-6upjA:
17.8		 3ekqA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ARG A   8
ASP A  25
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.82A 3ekqB-6upjA:
17.5		 3ekqB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.82A 3ekqB-6upjA:
17.5		 3ekqB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.43A 3ektA-6upjA:
18.1		 3ektA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.77A 3ektA-6upjA:
18.1		 3ektA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.82A 3ektB-6upjA:
18.0		 3ektB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
None
 0.69A 3ektD-6upjA:
17.9		 3ektD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.89A 3ektD-6upjA:
17.9		 3ektD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.64A 3ektD-6upjA:
17.9		 3ektD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.74A 3ektD-6upjA:
17.9		 3ektD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.09A 3ektD-6upjA:
17.9		 3ektD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
None
 0.61A 3ekvA-6upjA:
17.7		 3ekvA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.74A 3ekvA-6upjA:
17.7		 3ekvA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.70A 3ekvB-6upjA:
17.6		 3ekvB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.91A 3ekvB-6upjA:
17.6		 3ekvB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.73A 3ekvB-6upjA:
17.6		 3ekvB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.95A 3ekvB-6upjA:
17.6		 3ekvB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.95A 3ekwA-6upjA:
17.9		 3ekwA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 1.03A 3ekwA-6upjA:
17.9		 3ekwA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 1.40A 3ekwA-6upjA:
17.9		 3ekwA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.66A 3ekwB-6upjA:
17.4		 3ekwB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.85A 3ekwB-6upjA:
17.4		 3ekwB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.58A 3ekwB-6upjA:
17.4		 3ekwB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.69A 3ekwB-6upjA:
17.4		 3ekwB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
PRO A  81
 NIU  A 100 (-3.6A)
None
None
None
None
None
 0.86A 3ekxA-6upjA:
17.7		 3ekxA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.65A 3ekxA-6upjA:
17.7		 3ekxA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
None
 0.52A 3ekxA-6upjA:
17.7		 3ekxA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.86A 3ekxA-6upjA:
17.7		 3ekxA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 GLY A  27
ASP A  29
ASP A  30
ILE A  50
THR A  80
PRO A  81
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
None
 0.82A 3ekxA-6upjA:
17.7		 3ekxA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-3.6A)
None
None
None
None
 0.82A 3ekxB-6upjA:
17.8		 3ekxB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.86A 3ekxB-6upjA:
17.8		 3ekxB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.90A 3ekxB-6upjA:
17.8		 3ekxB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.47A 3ekyA-6upjA:
17.8		 3ekyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.83A 3ekyA-6upjA:
17.8		 3ekyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 ARG A   8
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.91A 3ekyA-6upjA:
17.8		 3ekyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ARG A   8
ASP A  25
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.91A 3ekyB-6upjA:
17.6		 3ekyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.49A 3ekyB-6upjA:
17.6		 3ekyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.86A 3ekyB-6upjA:
17.6		 3ekyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.49A 3ekyB-6upjA:
17.6		 3ekyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
None
 0.57A 3el0A-6upjA:
17.4		 3el0A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.70A 3el0B-6upjA:
17.7		 3el0B-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.76A 3el1A-6upjA:
17.9		 3el1A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ARG A   8
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.89A 3el1A-6upjA:
17.9		 3el1A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.67A 3el1A-6upjA:
17.9		 3el1A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.65A 3el1A-6upjA:
17.9		 3el1A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 LEU A  23
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.88A 3el1A-6upjA:
17.9		 3el1A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 LEU A  23
GLY A  27
ASP A  29
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
 0.91A 3el1A-6upjA:
17.9		 3el1A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
PRO A  81
 NIU  A 100 (-3.6A)
None
None
None
None
None
 0.88A 3el4A-6upjA:
17.9		 3el4A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.72A 3el4A-6upjA:
17.9		 3el4A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.40A 3el4A-6upjA:
17.9		 3el4A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.92A 3el4A-6upjA:
17.9		 3el4A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 GLY A  27
ASP A  29
ASP A  30
ILE A  50
THR A  80
PRO A  81
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
None
 0.76A 3el4A-6upjA:
17.9		 3el4A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ARG A   8
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.90A 3el4B-6upjA:
18.2		 3el4B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.92A 3el5A-6upjA:
17.8		 3el5A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
PRO A  81
 NIU  A 100 (-3.6A)
None
None
None
None
None
 0.93A 3el5B-6upjA:
17.6		 3el5B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.65A 3el5B-6upjA:
17.6		 3el5B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 8 ARG A   8
ALA A  28
ASP A  29
GLY A  49
 None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.84A 3el9A-6upjA:
17.5		 3el9A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 8 ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.55A 3el9A-6upjA:
17.5		 3el9A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 8 ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.74A 3el9A-6upjA:
17.5		 3el9A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.94A 3el9B-6upjA:
17.9		 3el9B-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.60A 3em3B-6upjA:
18.1		 3em3B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
None
None
 0.70A 3em3B-6upjA:
18.1		 3em3B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.88A 3em4A-6upjA:
17.8		 3em4A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.80A 3em4B-6upjA:
17.9		 3em4B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.83A 3em4U-6upjA:
18.3		 3em4U-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ARG A   8
ASP A  25
ASP A  29
GLY A  48
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
None
 0.89A 3em4V-6upjA:
18.1		 3em4V-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ASP A  29
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.67A 3em4V-6upjA:
18.1		 3em4V-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.88A 3gguA-6upjA:
18.7		 3gguA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.67A 3gguA-6upjA:
18.7		 3gguA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.78A 3gguA-6upjA:
18.7		 3gguA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.03A 3gguB-6upjA:
18.7		 3gguB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.68A 3gguB-6upjA:
18.7		 3gguB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.81A 3gguB-6upjA:
18.7		 3gguB-6upjA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JB2_A_SAMA1102_0
(STRUCTURAL PROTEIN
VP3)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ILE A  50
GLY A  49
GLY A  48
ALA A  28
PRO A  81
 NIU  A 100 (-3.9A)
NIU  A 100 ( 3.8A)
None
NIU  A 100 (-3.6A)
None
 1.00A 3jb2A-6upjA:
undetectable		 3jb2A-6upjA:
7.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.68A 3jvyA-6upjA:
18.1		 3jvyA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.74A 3jvyA-6upjA:
18.1		 3jvyA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.94A 3jvyA-6upjA:
18.1		 3jvyA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.95A 3jvyA-6upjA:
18.1		 3jvyA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.58A 3jvyB-6upjA:
17.8		 3jvyB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.71A 3jvyB-6upjA:
17.8		 3jvyB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_4
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 4 ARG A   8
ASP A  29
GLY A  48
THR A  80
 None
 1.26A 3k4vB-6upjA:
17.9		 3k4vB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.68A 3k4vC-6upjA:
18.1		 3k4vC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.75A 3k4vC-6upjA:
18.1		 3k4vC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 4 GLY A  27
ASP A  29
GLY A  48
THR A  80
 NIU  A 100 (-4.5A)
None
None
None
 0.51A 3k4vC-6upjA:
18.1		 3k4vC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.55A 3k4vD-6upjA:
17.7		 3k4vD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.52A 3k4vD-6upjA:
17.7		 3k4vD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.90A 3k4vD-6upjA:
17.7		 3k4vD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
GLY A  27
ASP A  29
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
None
 0.69A 3k4vD-6upjA:
17.7		 3k4vD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.63A 3lzsA-6upjA:
18.2		 3lzsA-6upjA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.60A 3lzsA-6upjA:
18.2		 3lzsA-6upjA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.85A 3lzsA-6upjA:
18.2		 3lzsA-6upjA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.22A 3lzsA-6upjA:
18.2		 3lzsA-6upjA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.78A 3lzsA-6upjA:
18.2		 3lzsA-6upjA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.64A 3lzsB-6upjA:
18.1		 3lzsB-6upjA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.60A 3lzsB-6upjA:
18.1		 3lzsB-6upjA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.82A 3lzsB-6upjA:
18.1		 3lzsB-6upjA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.69A 3lzuA-6upjA:
18.0		 3lzuA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.87A 3lzuA-6upjA:
18.0		 3lzuA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.64A 3lzuA-6upjA:
18.0		 3lzuA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.78A 3lzuA-6upjA:
18.0		 3lzuA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.50A 3lzvA-6upjA:
17.7		 3lzvA-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.69A 3lzvA-6upjA:
17.7		 3lzvA-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ARG A   8
ASP A  25
ALA A  28
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.70A 3lzvB-6upjA:
17.6		 3lzvB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.93A 3lzvB-6upjA:
17.6		 3lzvB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.75A 3lzvB-6upjA:
17.6		 3lzvB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.01A 3lzvB-6upjA:
17.6		 3lzvB-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.65A 3mwsA-6upjA:
18.4		 3mwsA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.63A 3mwsA-6upjA:
18.4		 3mwsA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.60A 3mwsA-6upjA:
18.4		 3mwsA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.66A 3mwsA-6upjA:
18.4		 3mwsA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.06A 3mwsA-6upjA:
18.4		 3mwsA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.92A 3mwsA-6upjA:
18.4		 3mwsA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.67A 3mwsB-6upjA:
18.5		 3mwsB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.92A 3mwsB-6upjA:
18.5		 3mwsB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.56A 3mwsB-6upjA:
18.5		 3mwsB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.65A 3mwsB-6upjA:
18.5		 3mwsB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.86A 3mwsB-6upjA:
18.5		 3mwsB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.91A 3mwsB-6upjA:
18.5		 3mwsB-6upjA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N3I_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.71A 3n3iA-6upjA:
12.6		 3n3iA-6upjA:
28.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.65A 3ndtC-6upjA:
18.1		 3ndtC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
GLY A  27
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.75A 3ndtC-6upjA:
18.1		 3ndtC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.54A 3ndtC-6upjA:
18.1		 3ndtC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.60A 3ndtC-6upjA:
18.1		 3ndtC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.65A 3ndtC-6upjA:
18.1		 3ndtC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
None
 0.69A 3ndtC-6upjA:
18.1		 3ndtC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.54A 3ndtD-6upjA:
17.8		 3ndtD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.54A 3ndtD-6upjA:
17.8		 3ndtD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.89A 3ndtD-6upjA:
17.8		 3ndtD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
GLY A  27
ASP A  29
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
None
 0.71A 3ndtD-6upjA:
17.8		 3ndtD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.56A 3nduA-6upjA:
17.9		 3nduA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.67A 3nduA-6upjA:
17.9		 3nduA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
None
None
 0.70A 3nduA-6upjA:
17.9		 3nduA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.82A 3nduA-6upjA:
17.9		 3nduA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.71A 3nduB-6upjA:
18.0		 3nduB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.88A 3nduB-6upjA:
18.0		 3nduB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
GLY A  27
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.78A 3nduC-6upjA:
18.1		 3nduC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.73A 3nduC-6upjA:
18.1		 3nduC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.58A 3nduD-6upjA:
17.5		 3nduD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.52A 3nduD-6upjA:
17.5		 3nduD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
GLY A  27
ASP A  29
ASP A  30
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
 0.72A 3nduD-6upjA:
17.5		 3nduD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.51A 3ndwA-6upjA:
17.8		 3ndwA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.50A 3ndwA-6upjA:
17.8		 3ndwA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  27
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.72A 3ndwA-6upjA:
17.8		 3ndwA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.77A 3ndwB-6upjA:
17.9		 3ndwB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.50A 3ndxA-6upjA:
17.8		 3ndxA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.47A 3ndxA-6upjA:
17.8		 3ndxA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.67A 3ndxA-6upjA:
17.8		 3ndxA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
PRO A  81
ILE A  84
 None
None
NIU  A 100 (-2.8A)
None
None
None
 0.69A 3nu3A-6upjA:
17.8		 3nu3A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.91A 3nu3A-6upjA:
17.8		 3nu3A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.88A 3nu3A-6upjA:
17.8		 3nu3A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.69A 3nu3A-6upjA:
17.8		 3nu3A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.86A 3nu3A-6upjA:
17.8		 3nu3A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.87A 3nu3B-6upjA:
17.5		 3nu3B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.79A 3nu3B-6upjA:
17.5		 3nu3B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.58A 3nu4A-6upjA:
17.9		 3nu4A-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.95A 3nu4A-6upjA:
17.9		 3nu4A-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.78A 3nu4A-6upjA:
17.9		 3nu4A-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  32
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.77A 3nu4B-6upjA:
17.3		 3nu4B-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.60A 3nu5B-6upjA:
17.6		 3nu5B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.58A 3nu5B-6upjA:
17.6		 3nu5B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.70A 3nu6A-6upjA:
17.7		 3nu6A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.93A 3nu6A-6upjA:
17.7		 3nu6A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.74A 3nu6B-6upjA:
17.7		 3nu6B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 (-3.9A)
None
 0.54A 3nu6B-6upjA:
17.7		 3nu6B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 8 ASP A  25
ALA A  28
ASP A  30
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
 0.58A 3nu9A-6upjA:
17.7		 3nu9A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.65A 3nu9B-6upjA:
17.8		 3nu9B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.74A 3nu9B-6upjA:
17.8		 3nu9B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.61A 3nujA-6upjA:
17.9		 3nujA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.72A 3nujA-6upjA:
17.9		 3nujA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.70A 3nujB-6upjA:
17.5		 3nujB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.58A 3nuoA-6upjA:
17.8		 3nuoA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.99A 3nuoA-6upjA:
17.8		 3nuoA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.75A 3nuoA-6upjA:
17.8		 3nuoA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.77A 3nuoB-6upjA:
17.4		 3nuoB-6upjA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_A_017A200_1
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  50
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 (-3.9A)
 0.61A 3ogpA-6upjA:
15.5		 3ogpA-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_A_017A200_1
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.81A 3ogpA-6upjA:
15.5		 3ogpA-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_B_017B200_1
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.94A 3ogpA-6upjA:
15.5		 3ogpA-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_B_017B200_2
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.72A 3ogpB-6upjA:
15.5		 3ogpB-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_B_017B200_2
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.83A 3ogpB-6upjA:
15.5		 3ogpB-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_1
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.87A 3ogqA-6upjA:
15.4		 3ogqA-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.95A 3ogqB-6upjA:
15.4		 3ogqB-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.79A 3ogqB-6upjA:
15.4		 3ogqB-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
 0.82A 3ogqB-6upjA:
15.4		 3ogqB-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.94A 3ogqB-6upjA:
15.4		 3ogqB-6upjA:
29.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.59A 3oxcA-6upjA:
17.7		 3oxcA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.41A 3oxcA-6upjA:
17.7		 3oxcA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.74A 3oxcA-6upjA:
17.7		 3oxcA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.76A 3oxcB-6upjA:
18.3		 3oxcB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.79A 3oxcB-6upjA:
18.3		 3oxcB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.65A 3oxcB-6upjA:
18.3		 3oxcB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.60A 3oxcB-6upjA:
18.3		 3oxcB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.63A 3oxvA-6upjA:
18.2		 3oxvA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.71A 3oxvB-6upjA:
17.9		 3oxvB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.73A 3oxvB-6upjA:
17.9		 3oxvB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.66A 3oxvC-6upjA:
18.5		 3oxvC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.70A 3oxvD-6upjA:
18.0		 3oxvD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.68A 3oxvD-6upjA:
18.0		 3oxvD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.90A 3oxvD-6upjA:
18.0		 3oxvD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.71A 3oxwA-6upjA:
18.4		 3oxwA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.70A 3oxwB-6upjA:
18.1		 3oxwB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.68A 3oxwC-6upjA:
18.3		 3oxwC-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.69A 3oxwD-6upjA:
18.1		 3oxwD-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
ALA A  28
ASP A  29
GLY A  49
PRO A  81
 None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.98A 3oxxA-6upjA:
18.0		 3oxxA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.70A 3oxxA-6upjA:
18.0		 3oxxA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.57A 3oxxA-6upjA:
18.0		 3oxxA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.65A 3oxxB-6upjA:
18.2		 3oxxB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.74A 3oxxC-6upjA:
17.8		 3oxxC-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.67A 3oxxC-6upjA:
17.8		 3oxxC-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
 0.66A 3oy4A-6upjA:
17.5		 3oy4A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.78A 3oy4A-6upjA:
17.5		 3oy4A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.98A 3oy4A-6upjA:
17.5		 3oy4A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.87A 3oy4A-6upjA:
17.5		 3oy4A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.80A 3oy4A-6upjA:
17.5		 3oy4A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.84A 3oy4A-6upjA:
17.5		 3oy4A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.96A 3oy4A-6upjA:
17.5		 3oy4A-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.45A 3oy4B-6upjA:
17.7		 3oy4B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.68A 3oy4B-6upjA:
17.7		 3oy4B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.64A 3pwmA-6upjA:
17.9		 3pwmA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.70A 3pwmA-6upjA:
17.9		 3pwmA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.68A 3pwmA-6upjA:
17.9		 3pwmA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.98A 3pwmA-6upjA:
17.9		 3pwmA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.95A 3pwmA-6upjA:
17.9		 3pwmA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.64A 3pwmB-6upjA:
17.6		 3pwmB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.71A 3pwmB-6upjA:
17.6		 3pwmB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.61A 3pwrA-6upjA:
17.9		 3pwrA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.58A 3pwrA-6upjA:
17.9		 3pwrA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
GLY A  27
ASP A  29
ASP A  30
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
 0.85A 3pwrA-6upjA:
17.9		 3pwrA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.62A 3pwrB-6upjA:
17.7		 3pwrB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
GLY A  27
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.79A 3pwrB-6upjA:
17.7		 3pwrB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ASP A  25
ALA A  28
ASP A  30
ILE A  32
VAL A  47
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-4.6A)
None
 0.69A 3s43A-6upjA:
17.8		 3s43A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 (-4.6A)
None
 0.81A 3s43A-6upjA:
17.8		 3s43A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  25
ALA A  28
VAL A  47
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.73A 3s43A-6upjA:
17.8		 3s43A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  32
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.69A 3s43B-6upjA:
17.4		 3s43B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ILE A  32
VAL A  47
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.72A 3s43B-6upjA:
17.4		 3s43B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ASP A  30
ILE A  32
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.78A 3s43B-6upjA:
17.4		 3s43B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  32
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.60A 3s43B-6upjA:
17.4		 3s43B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ASP A  30
ILE A  32
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
 0.62A 3s43B-6upjA:
17.4		 3s43B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ILE A  32
VAL A  47
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.80A 3s43B-6upjA:
17.4		 3s43B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 ASP A  25
ALA A  28
ASP A  30
ILE A  32
GLY A  49
PRO A  81
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
NIU  A 100 (-4.6A)
None
 0.67A 3s45A-6upjA:
19.0		 3s45A-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-4.6A)
None
 0.98A 3s45A-6upjA:
19.0		 3s45A-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ASP A  25
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
NIU  A 100 (-4.6A)
None
 0.87A 3s45A-6upjA:
19.0		 3s45A-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-4.6A)
None
 0.54A 3s45B-6upjA:
19.2		 3s45B-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.57A 3s45B-6upjA:
19.2		 3s45B-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  50
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
NIU  A 100 (-4.6A)
None
 0.61A 3s45B-6upjA:
19.2		 3s45B-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-4.6A)
None
 0.69A 3s45B-6upjA:
19.2		 3s45B-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.65A 3s45B-6upjA:
19.2		 3s45B-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
NIU  A 100 (-4.6A)
None
 0.79A 3s45B-6upjA:
19.2		 3s45B-6upjA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  48
ILE A  82
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
NIU  A 100 (-4.6A)
 0.98A 3s53A-6upjA:
16.9		 3s53A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.79A 3s53A-6upjA:
16.9		 3s53A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
ILE A  82
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-4.6A)
 0.53A 3s53A-6upjA:
16.9		 3s53A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ASP A  30
ILE A  82
ILE A  84
 None
None
NIU  A 100 (-2.8A)
None
NIU  A 100 (-4.6A)
None
 0.84A 3s53B-6upjA:
17.8		 3s53B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.70A 3s53B-6upjA:
17.8		 3s53B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ARG A   8
LEU A  23
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.95A 3s53B-6upjA:
17.8		 3s53B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
ALA A  28
ASP A  30
ILE A  32
PRO A  81
ILE A  82
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-4.6A)
None
 0.70A 3s53B-6upjA:
17.8		 3s53B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ASP A  25
ALA A  28
ILE A  32
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.69A 3s53B-6upjA:
17.8		 3s53B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.95A 3s53B-6upjA:
17.8		 3s53B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ASP A  30
ILE A  32
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 (-4.6A)
None
 0.78A 3s53B-6upjA:
17.8		 3s53B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 LEU A  23
ASP A  25
ILE A  32
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
None
 0.64A 3s53B-6upjA:
17.8		 3s53B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 LEU A  23
ILE A  32
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.91A 3s53B-6upjA:
17.8		 3s53B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
THR A  80
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.73A 3s56A-6upjA:
17.4		 3s56A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
ALA A  28
ILE A  32
VAL A  47
GLY A  49
THR A  80
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.67A 3s56A-6upjA:
17.4		 3s56A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  82
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
NIU  A 100 (-4.6A)
 0.65A 3s56A-6upjA:
17.4		 3s56A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ILE A  32
VAL A  47
THR A  80
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.61A 3s56A-6upjA:
17.4		 3s56A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  29
ASP A  30
GLY A  48
THR A  80
PRO A  81
 None
 1.12A 3s56A-6upjA:
17.4		 3s56A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.90A 3s56A-6upjA:
17.4		 3s56A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 GLY A  27
ASP A  29
ASP A  30
ILE A  50
THR A  80
PRO A  81
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
None
 0.73A 3s56A-6upjA:
17.4		 3s56A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  27
ILE A  32
ILE A  50
THR A  80
PRO A  81
 NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
None
 0.66A 3s56A-6upjA:
17.4		 3s56A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ILE A  32
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.71A 3s56A-6upjA:
17.4		 3s56A-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.90A 3s56B-6upjA:
17.7		 3s56B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ARG A   8
ASP A  25
ASP A  30
PRO A  81
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 (-4.6A)
None
 1.10A 3s56B-6upjA:
17.7		 3s56B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ASP A  30
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 None
None
None
NIU  A 100 (-4.6A)
None
 0.84A 3s56B-6upjA:
17.7		 3s56B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.75A 3s56B-6upjA:
17.7		 3s56B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 LEU A  23
ASP A  25
ASP A  30
PRO A  81
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 (-4.6A)
None
 0.88A 3s56B-6upjA:
17.7		 3s56B-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
NIU  A 100 (-3.6A)
None
None
None
 0.94A 3so9B-6upjA:
17.7		 3so9B-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.12A 3so9B-6upjA:
17.7		 3so9B-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
LEU A  23
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.72A 3spkA-6upjA:
18.3		 3spkA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.49A 3spkA-6upjA:
18.3		 3spkA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.95A 3spkA-6upjA:
18.3		 3spkA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ARG A   8
LEU A  23
ALA A  28
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.76A 3spkA-6upjA:
18.3		 3spkA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.72A 3spkB-6upjA:
18.5		 3spkB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.48A 3spkB-6upjA:
18.5		 3spkB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.77A 3spkB-6upjA:
18.5		 3spkB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.33A 3t3cA-6upjA:
17.9		 3t3cA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 7 ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  50
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
 0.50A 3t3cA-6upjA:
17.9		 3t3cA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.72A 3tkgA-6upjA:
17.6		 3tkgA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.79A 3tkgA-6upjA:
17.6		 3tkgA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.67A 3tkgB-6upjA:
17.7		 3tkgB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.87A 3tkgB-6upjA:
17.7		 3tkgB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.68A 3tkgB-6upjA:
17.7		 3tkgB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.89A 3tkgB-6upjA:
17.7		 3tkgB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
THR A  80
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
None
None
None
 0.61A 3tkgC-6upjA:
17.6		 3tkgC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
None
 0.75A 3tkgC-6upjA:
17.6		 3tkgC-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.74A 3tkgD-6upjA:
18.0		 3tkgD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.88A 3tkgD-6upjA:
18.0		 3tkgD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.61A 3tkgD-6upjA:
18.0		 3tkgD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.74A 3tkgD-6upjA:
18.0		 3tkgD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.86A 3tkgD-6upjA:
18.0		 3tkgD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_3
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.53A 3tkgD-6upjA:
18.0		 3tkgD-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.64A 3tkwA-6upjA:
18.2		 3tkwA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.72A 3tkwA-6upjA:
18.2		 3tkwA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_4
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 4 ASP A  29
ASP A  30
GLY A  48
THR A  80
 None
 0.66A 3tl9B-6upjA:
17.1		 3tl9B-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ALA A  28
ASP A  30
GLY A  49
ILE A  50
LEU A  23
ILE A  84
 NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.21A 3ttpA-6upjA:
18.7		 3ttpA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.76A 3ttpA-6upjA:
18.7		 3ttpA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.76A 3ttpA-6upjA:
18.7		 3ttpA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ALA A  28
ASP A  30
GLY A  49
ILE A  50
LEU A  23
ILE A  84
 NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.24A 3ttpB-6upjA:
18.7		 3ttpB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.78A 3ttpB-6upjA:
18.7		 3ttpB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.78A 3ttpB-6upjA:
18.7		 3ttpB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.42A 3u7sA-6upjA:
18.5		 3u7sA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.68A 3u7sA-6upjA:
18.5		 3u7sA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.83A 3u7sB-6upjA:
18.7		 3u7sB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.89A 3u7sB-6upjA:
18.7		 3u7sB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ALA A  28
ASP A  30
GLY A  49
ILE A  50
LEU A  23
 NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.98A 3u7sA-6upjA:
18.5		 3u7sA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_1
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.81A 3u7sA-6upjA:
18.5		 3u7sA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_2
(POL POLYPROTEIN)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.76A 3u7sB-6upjA:
18.7		 3u7sB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  32
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.86A 3ucbA-6upjA:
18.3		 3ucbA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
 0.71A 3ucbA-6upjA:
18.3		 3ucbA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
ILE A  32
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.76A 3ucbA-6upjA:
18.3		 3ucbA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.05A 3ucbA-6upjA:
18.3		 3ucbA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
ALA A  28
ILE A  32
VAL A  47
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
 0.71A 3ucbB-6upjA:
18.3		 3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  47
GLY A  49
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.75A 3ucbB-6upjA:
18.3		 3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.61A 3ucbB-6upjA:
18.3		 3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
 0.67A 3ucbB-6upjA:
18.3		 3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
ILE A  32
VAL A  47
PRO A  81
 None
NIU  A 100 (-2.8A)
None
None
None
 0.62A 3ucbB-6upjA:
18.3		 3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
VAL A  47
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.87A 3ucbB-6upjA:
18.3		 3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  30
VAL A  47
GLY A  49
ILE A  50
PRO A  81
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.20A 3ucbB-6upjA:
18.3		 3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  47
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.91A 3ufnA-6upjA:
18.4		 3ufnA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
VAL A  47
GLY A  48
GLY A  49
ILE A  50
THR A  80
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.81A 3ufnA-6upjA:
18.4		 3ufnA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		4 / 7 ASP A  25
VAL A  47
GLY A  49
ILE A  50
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.75A 3ufnB-6upjA:
18.6		 3ufnB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
 0.87A 3wsjA-6upjA:
12.1		 3wsjA-6upjA:
32.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.47A 4dqbB-6upjA:
18.1		 4dqbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.71A 4dqbB-6upjA:
18.1		 4dqbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.63A 4dqcA-6upjA:
17.5		 4dqcA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.97A 4dqcA-6upjA:
17.5		 4dqcA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.62A 4dqcA-6upjA:
17.5		 4dqcA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.93A 4dqcA-6upjA:
17.5		 4dqcA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.93A 4dqcA-6upjA:
17.5		 4dqcA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.48A 4dqcB-6upjA:
18.0		 4dqcB-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.73A 4dqcB-6upjA:
18.0		 4dqcB-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.69A 4dqeA-6upjA:
17.7		 4dqeA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.96A 4dqeA-6upjA:
17.7		 4dqeA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.90A 4dqeA-6upjA:
17.7		 4dqeA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.71A 4dqeA-6upjA:
17.7		 4dqeA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.95A 4dqeA-6upjA:
17.7		 4dqeA-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.46A 4dqeB-6upjA:
18.2		 4dqeB-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.68A 4dqeB-6upjA:
18.2		 4dqeB-6upjA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.79A 4dqhA-6upjA:
17.6		 4dqhA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.02A 4dqhA-6upjA:
17.6		 4dqhA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.90A 4dqhA-6upjA:
17.6		 4dqhA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.79A 4dqhA-6upjA:
17.6		 4dqhA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.99A 4dqhA-6upjA:
17.6		 4dqhA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.47A 4dqhB-6upjA:
18.0		 4dqhB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.70A 4dqhB-6upjA:
18.0		 4dqhB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.64A 4hlaA-6upjA:
17.9		 4hlaA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.79A 4hlaA-6upjA:
17.9		 4hlaA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.20A 4hlaA-6upjA:
17.9		 4hlaA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.84A 4hlaA-6upjA:
17.9		 4hlaA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.30A 4hlaA-6upjA:
17.9		 4hlaA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.67A 4hlaB-6upjA:
18.0		 4hlaB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.77A 4hlaB-6upjA:
18.0		 4hlaB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.64A 4hlaB-6upjA:
18.0		 4hlaB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.71A 4hlaB-6upjA:
18.0		 4hlaB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.33A 4hlaB-6upjA:
18.0		 4hlaB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
ILE A  32
VAL A  47
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.72A 4j5jB-6upjA:
18.5		 4j5jB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B401_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
VAL A  47
GLY A  49
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.91A 4j5jB-6upjA:
18.5		 4j5jB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
ILE A  84
 None
None
NIU  A 100 (-2.8A)
None
None
 0.59A 4jecB-6upjA:
17.9		 4jecB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.74A 4jecB-6upjA:
17.9		 4jecB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.62A 4jecB-6upjA:
17.9		 4jecB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.67A 4jecB-6upjA:
17.9		 4jecB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
 0.67A 4jecB-6upjA:
17.9		 4jecB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
None
 0.66A 4jecB-6upjA:
17.9		 4jecB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ARG A   8
ALA A  28
ASP A  29
ASP A  30
THR A  80
 None
NIU  A 100 (-3.6A)
None
None
None
 0.92A 4l1aA-6upjA:
15.9		 4l1aA-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ARG A   8
ALA A  28
ASP A  30
THR A  80
PRO A  81
 None
NIU  A 100 (-3.6A)
None
None
None
 0.95A 4l1aA-6upjA:
15.9		 4l1aA-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.71A 4l1aA-6upjA:
15.9		 4l1aA-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  30
PRO A  81
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.94A 4l1aA-6upjA:
15.9		 4l1aA-6upjA:
46.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.44A 4ll3B-6upjA:
17.9		 4ll3B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.73A 4ll3B-6upjA:
17.9		 4ll3B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.99A 4ll3A-6upjA:
17.8		 4ll3A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.47A 4ll3A-6upjA:
17.8		 4ll3A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.76A 4ll3A-6upjA:
17.8		 4ll3A-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.54A 4ll3B-6upjA:
17.9		 4ll3B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.65A 4ll3B-6upjA:
17.9		 4ll3B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.97A 4njtA-6upjA:
17.9		 4njtA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.77A 4njtA-6upjA:
17.9		 4njtA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.79A 4njtA-6upjA:
17.9		 4njtA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.92A 4njtA-6upjA:
17.9		 4njtA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.46A 4njtB-6upjA:
18.1		 4njtB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.71A 4njtB-6upjA:
18.1		 4njtB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.95A 4njtC-6upjA:
18.0		 4njtC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.71A 4njtC-6upjA:
18.0		 4njtC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.73A 4njtC-6upjA:
18.0		 4njtC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.87A 4njtC-6upjA:
18.0		 4njtC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
 0.58A 4njtD-6upjA:
18.1		 4njtD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.87A 4njuA-6upjA:
18.3		 4njuA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.48A 4njuA-6upjA:
18.3		 4njuA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.74A 4njuB-6upjA:
17.9		 4njuB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.86A 4njuC-6upjA:
18.2		 4njuC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.46A 4njuC-6upjA:
18.2		 4njuC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.75A 4njuD-6upjA:
18.0		 4njuD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
GLY A  27
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.02A 4njvA-6upjA:
18.4		 4njvA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.52A 4njvA-6upjA:
18.4		 4njvA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.58A 4njvA-6upjA:
18.4		 4njvA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  51
ILE A  50
PRO A  81
THR A  80
ILE A  54
 None
NIU  A 100 (-3.9A)
None
None
None
 0.97A 4njvA-6upjA:
18.4		 4njvA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.89A 4njvB-6upjA:
18.1		 4njvB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.39A 4njvC-6upjA:
18.5		 4njvC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ARG A   8
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.93A 4njvC-6upjA:
18.5		 4njvC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 1.32A 4njvC-6upjA:
18.5		 4njvC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.76A 4njvC-6upjA:
18.5		 4njvC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.58A 4njvD-6upjA:
18.1		 4njvD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.71A 4njvD-6upjA:
18.1		 4njvD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.46A 4q1wA-6upjA:
17.8		 4q1wA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.70A 4q1wA-6upjA:
17.8		 4q1wA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  30
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
 0.62A 4q1wB-6upjA:
17.3		 4q1wB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ARG A   8
ASP A  25
ALA A  28
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.77A 4q1wB-6upjA:
17.3		 4q1wB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ARG A   8
ASP A  25
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.06A 4q1wB-6upjA:
17.3		 4q1wB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.74A 4q1wB-6upjA:
17.3		 4q1wB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.98A 4q1wB-6upjA:
17.3		 4q1wB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.76A 4q1wB-6upjA:
17.3		 4q1wB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.98A 4q1wB-6upjA:
17.3		 4q1wB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  48
 NIU  A 100 (-3.6A)
None
None
None
None
 0.85A 4q1yA-6upjA:
17.9		 4q1yA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.46A 4q1yA-6upjA:
17.9		 4q1yA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.73A 4q1yA-6upjA:
17.9		 4q1yA-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
ASP A  25
ASP A  30
ILE A  32
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
None
 0.62A 4q1yB-6upjA:
17.6		 4q1yB-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
ILE A  84
 None
None
NIU  A 100 (-2.8A)
None
None
 0.61A 4q1yB-6upjA:
17.6		 4q1yB-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.82A 4q1yB-6upjA:
17.6		 4q1yB-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.67A 4q1yB-6upjA:
17.6		 4q1yB-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.75A 4q1yB-6upjA:
17.6		 4q1yB-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
None
 0.72A 4q1yB-6upjA:
17.6		 4q1yB-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.76A 4q1yB-6upjA:
17.6		 4q1yB-6upjA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q5M_A_ROCA1101_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.84A 4q5mA-6upjA:
15.3		 4q5mA-6upjA:
26.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q5M_A_ROCA1101_2
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 GLY A  27
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
None
None
 0.75A 4q5mA-6upjA:
15.3		 4q5mA-6upjA:
26.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.82A 4qgiA-6upjA:
17.8		 4qgiA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.01A 4qgiA-6upjA:
17.8		 4qgiA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.74A 4rvjA-6upjA:
17.8		 4rvjA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.87A 4rvjA-6upjA:
17.8		 4rvjA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.77A 4rvjB-6upjA:
17.6		 4rvjB-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.72A 4rvjC-6upjA:
17.8		 4rvjC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.86A 4rvjC-6upjA:
17.8		 4rvjC-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.77A 4rvjD-6upjA:
17.6		 4rvjD-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
 0.62A 5e5jA-6upjA:
18.0		 5e5jA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-4.6A)
None
 0.63A 5e5jA-6upjA:
18.0		 5e5jA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
 0.63A 5e5jA-6upjA:
18.0		 5e5jA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  32
VAL A  47
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-4.6A)
None
 0.74A 5e5jA-6upjA:
18.0		 5e5jA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.68A 5e5jA-6upjA:
18.0		 5e5jA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.70A 5e5jA-6upjA:
18.0		 5e5jA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-4.6A)
None
 0.88A 5e5kB-6upjA:
18.0		 5e5kB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  29
ILE A  32
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
None
 0.78A 5e5kB-6upjA:
18.0		 5e5kB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  29
ILE A  32
ILE A  82
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-4.6A)
None
 0.78A 5e5kB-6upjA:
18.0		 5e5kB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.82A 5e5kB-6upjA:
18.0		 5e5kB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
LEU A  23
GLY A  27
ASP A  29
ILE A  32
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.92A 5e5kB-6upjA:
18.0		 5e5kB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.78A 5e5kB-6upjA:
18.0		 5e5kB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-4.6A)
None
 0.74A 5e5kB-6upjA:
18.0		 5e5kB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
GLY A  27
ASP A  29
ILE A  32
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 (-3.9A)
None
None
 0.81A 5e5kB-6upjA:
18.0		 5e5kB-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_2
(PROTEASE E35D-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 ARG A   8
LEU A  23
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.78A 5kqxB-6upjA:
17.9		 5kqxB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_2
(PROTEASE E35D-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 LEU A  23
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.75A 5kqxB-6upjA:
17.9		 5kqxB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_1
(PROTEASE E35D-DRV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.72A 5kqyA-6upjA:
18.0		 5kqyA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_1
(PROTEASE E35D-DRV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.95A 5kqyA-6upjA:
18.0		 5kqyA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_1
(PROTEASE E35D-DRV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 LEU A  23
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
 0.72A 5kqyA-6upjA:
18.0		 5kqyA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_1
(PROTEASE E35D-DRV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.90A 5kqyA-6upjA:
18.0		 5kqyA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_2
(PROTEASE E35D-DRV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
 0.57A 5kqyB-6upjA:
17.7		 5kqyB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_2
(PROTEASE E35D-DRV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 7 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.71A 5kqyB-6upjA:
17.7		 5kqyB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_2
(PROTEASE E35D-APV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 LEU A  23
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.71A 5kr0B-6upjA:
17.7		 5kr0B-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_1
(PROTEASE PR5-DRV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ARG A   8
LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
 0.91A 5kr1A-6upjA:
17.6		 5kr1A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_1
(PROTEASE PR5-DRV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 10 ARG A   8
LEU A  23
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.97A 5kr1A-6upjA:
17.6		 5kr1A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
PRO A  81
 NIU  A 100 (-3.6A)
None
None
None
None
None
 0.98A 5kr2A-6upjA:
17.4		 5kr2A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.09A 5kr2A-6upjA:
17.4		 5kr2A-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.81A 5kr2B-6upjA:
18.0		 5kr2B-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 11 LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.72A 5kr2B-6upjA:
18.0		 5kr2B-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ALA A  28
ASP A  29
ASP A  30
GLY A  48
THR A  80
PRO A  81
 NIU  A 100 (-3.6A)
None
None
None
None
None
 0.84A 5kr2C-6upjA:
17.4		 5kr2C-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.94A 5kr2C-6upjA:
17.4		 5kr2C-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 9 ALA A  28
ASP A  29
ASP A  30
ILE A  50
THR A  80
PRO A  81
 NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
None
None
 0.81A 5kr2C-6upjA:
17.4		 5kr2C-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_2
(PROTEASE PR5-SQV)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 9 LEU A  23
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.69A 5kr2D-6upjA:
18.1		 5kr2D-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
None
 0.64A 5t2zA-6upjA:
18.4		 5t2zA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.65A 5t2zA-6upjA:
18.4		 5t2zA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.85A 5t2zA-6upjA:
18.4		 5t2zA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.81A 5t2zA-6upjA:
18.4		 5t2zA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
 None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.95A 5t8hA-6upjA:
17.8		 5t8hA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.79A 5t8hA-6upjA:
17.8		 5t8hA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 (-3.9A)
None
 0.62A 5t8hA-6upjA:
17.8		 5t8hA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  32
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.73A 5t8hA-6upjA:
17.8		 5t8hA-6upjA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.60A 6dgxA-6upjA:
18.1		 6dgxA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
ILE A  84
 None
None
NIU  A 100 (-2.8A)
None
None
 0.58A 6dgxB-6upjA:
17.5		 6dgxB-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
 0.73A 6dgxB-6upjA:
17.5		 6dgxB-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.71A 6dgxB-6upjA:
17.5		 6dgxB-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.78A 6dgxB-6upjA:
17.5		 6dgxB-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
None
 0.73A 6dgxB-6upjA:
17.5		 6dgxB-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.76A 6dgxB-6upjA:
17.5		 6dgxB-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.67A 6dh0A-6upjA:
18.1		 6dh0A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.63A 6dh3A-6upjA:
18.0		 6dh3A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  82
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-4.6A)
None
 0.56A 6dh3A-6upjA:
18.0		 6dh3A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  30
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
 0.65A 6dh3B-6upjA:
17.6		 6dh3B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
None
 0.79A 6dh3B-6upjA:
17.6		 6dh3B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.68A 6dh3B-6upjA:
17.6		 6dh3B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.75A 6dh3B-6upjA:
17.6		 6dh3B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.48A 6dh3B-6upjA:
17.6		 6dh3B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.68A 6dh3B-6upjA:
17.6		 6dh3B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
None
 0.70A 6dh3B-6upjA:
17.6		 6dh3B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.73A 6dh3B-6upjA:
17.6		 6dh3B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_0
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.63A 6dh6A-6upjA:
18.2		 6dh6A-6upjA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  30
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
 0.64A 6dh6B-6upjA:
17.4		 6dh6B-6upjA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 ( 3.8A)
None
 0.80A 6dh6B-6upjA:
17.4		 6dh6B-6upjA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.72A 6dh6B-6upjA:
17.4		 6dh6B-6upjA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
 0.75A 6dh6B-6upjA:
17.4		 6dh6B-6upjA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
 0.48A 6dh6B-6upjA:
17.4		 6dh6B-6upjA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
 0.65A 6dh6B-6upjA:
17.4		 6dh6B-6upjA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
ASP A  30
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
None
 0.75A 6dh6B-6upjA:
17.4		 6dh6B-6upjA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
 0.74A 6dh6B-6upjA:
17.4		 6dh6B-6upjA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.74A 6difA-6upjA:
18.1		 6difA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.84A 6difA-6upjA:
18.1		 6difA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.89A 6difA-6upjA:
18.1		 6difA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
None
 0.64A 6difA-6upjA:
18.1		 6difA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
NIU  A 100 (-2.8A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.77A 6difA-6upjA:
18.1		 6difA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.78A 6difB-6upjA:
17.6		 6difB-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  50
ILE A  84
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
NIU  A 100 (-3.9A)
None
 0.69A 6difB-6upjA:
17.6		 6difB-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.84A 6dilA-6upjA:
18.2		 6dilA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 1.47A 6dilA-6upjA:
18.2		 6dilA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.84A 6dilA-6upjA:
18.2		 6dilA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.46A 6dilA-6upjA:
18.2		 6dilA-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.70A 6dj1A-6upjA:
18.0		 6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
 0.83A 6dj1A-6upjA:
18.0		 6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
 0.79A 6dj1A-6upjA:
18.0		 6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
 0.57A 6dj1A-6upjA:
18.0		 6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.83A 6dj1A-6upjA:
18.0		 6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
GLY A  27
GLY A  48
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
None
 0.68A 6dj1A-6upjA:
18.0		 6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
None
 0.83A 6dj1B-6upjA:
17.8		 6dj1B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.49A 6dj1B-6upjA:
17.8		 6dj1B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.81A 6dj1B-6upjA:
17.8		 6dj1B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 0.96A 6dj2A-6upjA:
18.0		 6dj2A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		7 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
 0.98A 6dj2A-6upjA:
18.0		 6dj2A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
None
 1.38A 6dj2A-6upjA:
18.0		 6dj2A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 (-3.9A)
None
 0.82A 6dj2B-6upjA:
17.8		 6dj2B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 1.48A 6dj2B-6upjA:
17.8		 6dj2B-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 6upj HIV-2 PROTEASE
(Human
immunodeficiency
virus
2) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
 0.81A 6dj2B-6upjA:
17.8		 6dj2B-6upjA:
47.50